首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   210309篇
  免费   15160篇
  国内免费   748篇
耳鼻咽喉   2284篇
儿科学   5482篇
妇产科学   4304篇
基础医学   27098篇
口腔科学   4511篇
临床医学   19997篇
内科学   44882篇
皮肤病学   2754篇
神经病学   20302篇
特种医学   6951篇
外国民族医学   13篇
外科学   32916篇
综合类   3411篇
现状与发展   2篇
一般理论   291篇
预防医学   19062篇
眼科学   4372篇
药学   14387篇
  1篇
中国医学   374篇
肿瘤学   12823篇
  2023年   843篇
  2022年   1403篇
  2021年   3439篇
  2020年   2105篇
  2019年   3390篇
  2018年   3967篇
  2017年   3212篇
  2016年   3410篇
  2015年   4066篇
  2014年   6095篇
  2013年   8822篇
  2012年   13124篇
  2011年   14319篇
  2010年   8096篇
  2009年   7304篇
  2008年   13588篇
  2007年   14424篇
  2006年   13918篇
  2005年   14392篇
  2004年   13806篇
  2003年   12899篇
  2002年   12435篇
  2001年   1873篇
  2000年   1457篇
  1999年   2045篇
  1998年   2828篇
  1997年   2437篇
  1996年   2205篇
  1995年   1953篇
  1994年   1755篇
  1993年   1655篇
  1992年   1208篇
  1991年   1149篇
  1990年   1053篇
  1989年   952篇
  1988年   1011篇
  1987年   1018篇
  1986年   999篇
  1985年   1082篇
  1984年   1478篇
  1983年   1461篇
  1982年   1814篇
  1981年   1639篇
  1980年   1555篇
  1979年   812篇
  1978年   958篇
  1977年   932篇
  1976年   832篇
  1975年   682篇
  1974年   666篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
13.
14.
15.
16.
Respiratory cysts are benign lesions lined by normal respiratory epithelium. There are few reported cases localized to the orbit, while those of the eyelid are exceedingly rare. Respiratory cysts usually arise either from a non‐hereditary congenital malformation, where they are distinguished as choristomatous, or from trauma. Here, we report a case of a 53‐year‐old man who presented with a large right lower eyelid cyst that was histopathologically diagnosed as a respiratory cyst.  相似文献   
17.
Graefe's Archive for Clinical and Experimental Ophthalmology - Retinal microvascular endothelial dysfunction is thought to be of importance in the development of ocular vascular diseases....  相似文献   
18.

Objectives

To investigate whether functional overreaching affects locomotor system behaviour when running at fixed relative intensities and if any effects were associated with changes in running performance.

Design

Prospective intervention study.

Methods

Ten trained male runners completed three training blocks in a fixed order. Training consisted of one week of light training (baseline), two weeks of heavy training designed to induce functional overreaching, and ten days of light taper training designed to allow athletes to recover from, and adapt to, the heavy training. Locomotor behaviour, 5-km time trial performance, and subjective reports of training status (Daily Analysis of Life Demands for Athletes (DALDA) questionnaire) were assessed at the completion of each training block. Locomotor behaviour was assessed using detrended fluctuation analysis of stride intervals during running at speeds corresponding to 65% and 85% of maximum heart rate (HRmax) at baseline.

Results

Time trial performance (effect size ±95% confidence interval (ES): 0.16 ± 0.06; p < 0.001), locomotor behaviour at 65% HRmax (ES: ?1.12 ± 0.95; p = 0.026), and DALDA (ES: 2.55 ± 0.80; p < 0.001) were all detrimentally affected by the heavy training. Time trial performance improved relative to baseline after the taper (ES: ?0.16 ± 0.10; p = 0.003) but locomotor behaviour at 65% HRmax (ES: ?1.18 ± 1.17; p = 0.048) and DALDA (ES: 0.92 ± 0.90; p = 0.045) remained impaired.

Conclusions

Locomotor behaviour during running at 65% HRmax was impaired by functional overreaching and remained impaired after a 10-day taper, despite improved running performance. Locomotor changes may increase injury risk and should be considered within athlete monitoring programs independently of performance changes.  相似文献   
19.
20.

Objective

To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.

Design

Observational nationwide cohort study.

Setting

Linked population data from the Australian Childhood Immunisation Register and National Death Index.

Participants

Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.

Main outcome measures

Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.

Results

The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.

Conclusion

Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号